Cargando…
Liquid biopsies and minimal residual disease in myeloid malignancies
Minimal residual disease (MRD) assessment through blood component sampling by liquid biopsies (LBs) is increasingly being investigated in myeloid malignancies. Blood components then undergo molecular analysis by flow cytometry or sequencing techniques and can be used as a powerful tool for prognosti...
Autores principales: | Allam, Sabine, Nasr, Kristina, Khalid, Farhan, Shah, Zunairah, Khan Suheb, Mahammed Ziauddin, Mulla, Sana, Vikash, Sindhu, Bou Zerdan, Maroun, Anwer, Faiz, Chaulagain, Chakra P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196237/ https://www.ncbi.nlm.nih.gov/pubmed/37213280 http://dx.doi.org/10.3389/fonc.2023.1164017 |
Ejemplares similares
-
Liquid biopsies and minimal residual disease in lymphoid malignancies
por: Bou Zerdan, Maroun, et al.
Publicado: (2023) -
Multidisciplinary supportive care in systemic light chain amyloidosis
por: Maroun, Bou Zerdan, et al.
Publicado: (2022) -
Systemic AL amyloidosis: current approach and future direction
por: Bou Zerdan, Maroun, et al.
Publicado: (2023) -
Addendum: Systemic AL amyloidosis: current approach and future direction
por: Bou Zerdan, Maroun, et al.
Publicado: (2023) -
Predictors of Hospitalizations and Death from COVID-19 in Patients with Multiple Myeloma
por: Chaulagain, Chakra P, et al.
Publicado: (2022)